Suzhou Connect Biopharmaceuticals, Ltd.
HomeحContact UsحSite Map
NEWS
2017-02-28 08:30:00  -Connect Biopharmaceuticals Receives Approval to Initiate Clinical Trials of CBP-307 in China
2017-01-25 08:00:00  -Connect Biopharmaceuticals Completes $25 Million Financing to Advance Clinical Development of Novel Immune Modulators
2016-01-11 08:00:00  -Connect Biopharma CEO Invited to Attend the CABS Investor Forum 2016 in San Francisco During the Week of the JP Morgan Healthcare Conference
2016-01-08 08:00:00  -Suzhou Connect Biopharma Reports Positive Phase 1b Result for Novel S1P1 Modulator CBP-307 for Autoimmune Diseases
2015-07-30 08:00:00  -Suzhou Connect Biopharma Reports Positive Phase 1a Results for CBP-307, a Novel, Orally-active S1P1 Modulator for Autoimmune Diseases
2015-07-09 09:00:00  -Suzhou Connect Biopharma Announces Patent Issuance Covering CBP-307 C a Clinical-stage Second Generation S1P1 Immune Modulator
2015-02-12 10:00:00  -Connect Biopharma CEO Dr. Zheng Wei Selected to National Thousand Talents Plan
2014-11-20 17:15:00  -Suzhou Connect Biopharma Featured in BioWorld Today (Thomson Reuters)
2014-11-18 08:00:00  -Suzhou Connect Biopharma Announced Initiation of Phase I Trial of Novel Immune Modulator CBP-307
2014-09-26 10:00:00  -Suzhou Connect Biopharma awarded Outstanding Enterprise in China Innovation & Entrepreneurship Competition
2014-07-20 10:00:00  -Suzhou Connect Biopharma Established an Australian Subsidiary to Accelerate Clinical Development
2014-06-10 15:32:55  -Suzhou Connect Biopharma Received Award of Jiangsu Science and Technology Support Program
2013-12-08 16:11:20  -Dr. Zheng Wei, Co-founder and CEO of Suzhou Connect Biopharma, Received Award of Taicang Innovation and Entrepreneurship Leading Talent
2013-10-09 09:09:13  -Dr. Zheng Wei, Co-founder and CEO of Suzhou Connect Biopharma, Received Award of Jiangsu Innovation and Entrepreneurship Leading Talent
2012-12-26 16:46:57  -2012-12-17 Dr. Zheng Wei, Co-founder and CEO of Suzhou Connect Biopharma, Received Award of Suzhou (Gusu) Leading Talent
Copyright: Suzhou Connect Biopharmaceuticals, Ltd.